The human immunodeficiency virus Tat proteins specifically associate with TAK in vivo and require the carboxyl-terminal domain of RNA polymerase II for function
about
In vitro nuclear interactome of the HIV-1 Tat proteinTat-SF1 protein associates with RAP30 and human SPT5 proteinsA cofactor, TIP30, specifically enhances HIV-1 Tat-activated transcriptionPITALRE, the catalytic subunit of TAK, is required for human immunodeficiency virus Tat transactivation in vivo.Transcriptional activation of the integrated chromatin-associated human immunodeficiency virus type 1 promoterAnalysis of the effect of natural sequence variation in Tat and in cyclin T on the formation and RNA binding properties of Tat-cyclin T complexes.Sequence and transcriptional analyses of the fish retroviruses walleye epidermal hyperplasia virus types 1 and 2: evidence for a gene duplication.Purification of a Tat-associated kinase reveals a TFIIH complex that modulates HIV-1 transcriptionTranscription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stagesTranscriptional synergy between Tat and PCAF is dependent on the binding of acetylated Tat to the PCAF bromodomainRelief of two built-In autoinhibitory mechanisms in P-TEFb is required for assembly of a multicomponent transcription elongation complex at the human immunodeficiency virus type 1 promoterTranscriptional cofactor CA150 regulates RNA polymerase II elongation in a TATA-box-dependent mannerCoordination of transcription factor phosphorylation and histone methylation by the P-TEFb kinase during human immunodeficiency virus type 1 transcriptionThe HIV transactivator TAT binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase IIThe human immunodeficiency virus transactivator Tat interacts with the RNA polymerase II holoenzymeTat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcriptionEffects of histone acetylation and DNA methylation on p21( WAF1) regulationInhibition of human immunodeficiency virus type 1 replication in acutely and chronically infected cells by EM2487, a novel substance produced by a Streptomyces speciesP-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitroTAK, an HIV Tat-associated kinase, is a member of the cyclin-dependent family of protein kinases and is induced by activation of peripheral blood lymphocytes and differentiation of promonocytic cell linesTranscription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitroRegulation of human immunodeficiency virus type 1 gene expression by clade-specific Tat proteins.Cyclin T1-dependent genes in activated CD4 T and macrophage cell lines appear enriched in HIV-1 co-factors.Transcription of herpes simplex virus immediate-early and early genes is inhibited by roscovitine, an inhibitor specific for cellular cyclin-dependent kinasesMechanism and regulation of transcriptional elongation by RNA polymerase II.Modulation of Sp1 phosphorylation by human immunodeficiency virus type 1 Tat.Tat-associated kinase, TAK, activity is regulated by distinct mechanisms in peripheral blood lymphocytes and promonocytic cell linesHuman and rodent transcription elongation factor P-TEFb: interactions with human immunodeficiency virus type 1 tat and carboxy-terminal domain substrate.ICP22 and the UL13 protein kinase are both required for herpes simplex virus-induced modification of the large subunit of RNA polymerase II.Human GLI-2 is a tat activation response element-independent Tat cofactor.Tat activates human immunodeficiency virus type 1 transcriptional elongation independent of TFIIH kinase.Limited redundancy in genes regulated by Cyclin T2 and Cyclin T1.RNA polymerase II transcription elongation and Pol II CTD Ser2 phosphorylation: A tail of two kinases.Viral transactivators E1A and VP16 interact with a large complex that is associated with CTD kinase activity and contains CDK8Mapping sites of positive selection and amino acid diversification in the HIV genome: an alternative approach to vaccine design?The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 proteinCasein kinase II is a selective target of HIV-1 transcriptional inhibitors.MD simulation of the Tat/Cyclin T1/CDK9 complex revealing the hidden catalytic cavity within the CDK9 molecule upon Tat binding.HEXIM1 controls satellite cell expansion after injury to regulate skeletal muscle regenerationRecruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription.
P2860
Q21245051-54B1C4F9-4286-4E72-853D-A7FD6624E3DBQ22003803-09BAAB2F-5C75-45E3-AB74-A02A51D7B129Q24314052-A4E7ED15-0DB7-4BB8-95F4-A6F3D7895E12Q24523183-F93118CA-112F-4CAB-B27C-27875C939B5FQ24523709-DC5E9F6E-6ABB-4657-99D8-E09E0AAFA1C5Q24527261-CA80F0AF-D8A0-4696-86C0-1FBEFB2DE1BAQ24527316-110195A1-BB8D-47FF-90CC-CF816DDF62D2Q24532199-DB3FC222-53FC-4877-BAC6-D1B8BFD10BC8Q24533266-C6E6B1BB-A66B-4960-B2F4-AB0CFEF5DD7FQ24534907-C4F149C1-8DE8-477B-9218-457FEDF753FFQ24552532-74BC27E1-8968-4472-A3C7-1A8933A40977Q24554483-7F8BDF5C-EE0E-41B0-9BB2-7B078364E121Q24559797-D4F8D3DA-9EE7-4CD8-8E9E-96E9B99D41AFQ24605935-35F968B1-D4CC-477F-9A08-AD2D6FDA1162Q24646774-3BD9AB78-8A4C-47C9-88AE-EEF7742F87C5Q28116305-A7E91964-A951-440D-9449-2D4964DAE73CQ28202424-1F5E2543-CBA4-4787-84D3-69F99AF406B0Q28343602-8AAE1067-54DA-4FB3-B21B-BAE2B13A0018Q28379179-F0235D8D-AA46-44A5-A861-674F4DC36345Q28647556-142E1F8D-D89C-4D85-9E08-363CA3E09083Q29614788-E4E1EF65-7BF9-43CB-B6CC-CC357C8BB018Q30350982-0DFC57BA-ABC4-4AF1-9AA9-B906FFBB130BQ33367106-3AA54C95-EE2E-4FAA-B032-AB2E3A95B6CAQ33653316-64789A0C-8DA0-454B-BF41-27968B91575AQ33680820-26034F5A-49C6-484E-BBD7-6A59CCB37C7AQ33782959-95181ED6-BA90-423F-865F-5949387CD492Q33786066-2931B4E9-069B-4762-8852-D222849CF73BQ33815080-17437E0B-B5AB-44B7-8493-0B677D0D53CAQ33815308-911720B5-A837-4D4C-8DB3-E84785F3274DQ33850701-B71BC0CF-3B84-4DDD-9226-CE2F69C34DABQ33957746-5235DF6A-01E5-406D-A14C-DAFC526D4763Q33972021-53DD8DFC-6904-4333-883A-339FC2485F81Q34046663-D9C8AE84-B86A-4EA1-B746-8D4C3F9E5095Q34613177-F7B4D592-AAAF-4BAE-96DC-211A47F6F2AEQ34645213-719CEE14-F6BF-48D8-A3C8-82499EF33C69Q35211232-E52EEC32-832D-4BCC-BE37-983BCDE131DEQ36179377-2665500E-092B-4A8D-AA02-5C5B796E08A9Q36274198-AFA10ABB-ABA7-4CAB-B2FB-10EDF231D5C0Q36357842-A87F39C8-CE9E-4595-9FD5-CB976F0B4648Q36405698-EF4A1F8B-2D0E-4218-AF81-7C20CF560716
P2860
The human immunodeficiency virus Tat proteins specifically associate with TAK in vivo and require the carboxyl-terminal domain of RNA polymerase II for function
description
1996 nî lūn-bûn
@nan
1996 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
name
The human immunodeficiency vir ...... RNA polymerase II for function
@ast
The human immunodeficiency vir ...... RNA polymerase II for function
@en
The human immunodeficiency vir ...... RNA polymerase II for function
@nl
type
label
The human immunodeficiency vir ...... RNA polymerase II for function
@ast
The human immunodeficiency vir ...... RNA polymerase II for function
@en
The human immunodeficiency vir ...... RNA polymerase II for function
@nl
prefLabel
The human immunodeficiency vir ...... RNA polymerase II for function
@ast
The human immunodeficiency vir ...... RNA polymerase II for function
@en
The human immunodeficiency vir ...... RNA polymerase II for function
@nl
P2093
P2860
P1433
P1476
The human immunodeficiency vir ...... RNA polymerase II for function
@en
P2093
P2860
P304
P407
P577
1996-07-01T00:00:00Z